A detailed history of Marotta Asset Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Marotta Asset Management holds 16,653 shares of NVO stock, worth $1.77 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
16,653
Previous 16,925 1.61%
Holding current value
$1.77 Million
Previous $2.42 Million 17.93%
% of portfolio
0.39%
Previous 0.5%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$119.07 - $145.42 $32,387 - $39,554
-272 Reduced 1.61%
16,653 $1.98 Million
Q2 2024

Jul 17, 2024

SELL
$122.71 - $146.91 $36,935 - $44,219
-301 Reduced 1.75%
16,925 $2.42 Million
Q1 2024

Apr 02, 2024

SELL
$102.11 - $135.92 $12,048 - $16,038
-118 Reduced 0.68%
17,226 $2.21 Million
Q4 2023

Jan 03, 2024

SELL
$87.78 - $105.45 $13,693 - $16,450
-156 Reduced 0.89%
17,344 $1.79 Million
Q3 2023

Oct 11, 2023

BUY
$90.94 - $199.54 $783,084 - $1.72 Million
8,611 Added 96.87%
17,500 $1.59 Million
Q2 2023

Jul 05, 2023

SELL
$155.98 - $172.65 $8,266 - $9,150
-53 Reduced 0.59%
8,889 $1.44 Million
Q4 2022

Jan 03, 2023

SELL
$102.55 - $135.33 $40,814 - $53,861
-398 Reduced 4.26%
8,942 $0
Q3 2022

Oct 11, 2022

SELL
$95.28 - $116.93 $32,966 - $40,457
-346 Reduced 3.57%
9,340 $930,000
Q2 2022

Jul 21, 2022

SELL
$103.24 - $121.81 $103 - $121
-1 Reduced 0.01%
9,686 $1.08 Million
Q1 2022

Apr 08, 2022

SELL
$93.1 - $112.54 $112,278 - $135,723
-1,206 Reduced 11.07%
9,687 $1.08 Million
Q4 2021

Jan 13, 2022

BUY
$95.88 - $117.08 $76,704 - $93,664
800 Added 7.93%
10,893 $1.22 Million
Q3 2021

Oct 21, 2021

SELL
$84.42 - $106.62 $1,603 - $2,025
-19 Reduced 0.19%
10,093 $969,000
Q2 2021

Jul 09, 2021

BUY
$67.66 - $84.76 $80,718 - $101,118
1,193 Added 13.38%
10,112 $847,000
Q1 2021

Apr 09, 2021

BUY
$67.06 - $75.82 $598,108 - $676,238
8,919 New
8,919 $601,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marotta Asset Management Portfolio

Follow Marotta Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.